BFRG
NASDAQBullfrog AI Holdings Inc.
Price$0.68-0.01 (-0.91%)
01:30 PM04:15 PM
News · 26 weeks31+200%
2025-12-282026-06-21
Mix2190d
- SEC Filings12(57%)
- Other6(29%)
- Insider3(14%)
Latest news
25 items- SECBullfrog AI Holdings Inc. filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits8-K - BullFrog AI Holdings, Inc. (0001829247) (Filer)
- INSIDERSEC Form 4 filed by Director Hanson Jason David4 - BullFrog AI Holdings, Inc. (0001829247) (Issuer)
- INSIDERSEC Form 4 filed by Director Elsey R Don4 - BullFrog AI Holdings, Inc. (0001829247) (Issuer)
- INSIDERSEC Form 4 filed by Director Enright William4 - BullFrog AI Holdings, Inc. (0001829247) (Issuer)
- SECSEC Form EFFECT filed by Bullfrog AI Holdings Inc.EFFECT - BullFrog AI Holdings, Inc. (0001829247) (Filer)
- PRBullFrog AI Announces New Commercial Leadership Team to Execute Growth Strategy for its Integrated Pharma AI PlatformGAITHERSBURG, Md., June 02, 2026 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ:BFRG, BFRGW)) ("BullFrog AI" or the "Company"), a technology company using artificial intelligence ("AI") and machine learning to turn complex biomedical data into actionable insights, today announced it has appointed commercial technology sales and scientific-focused leaders to support the momentum of the Company's commercial business driven growth strategy. The new commercial management team brings combined expertise in scaling enterprise technology, implementing go-to-market strategic initiatives across global markets, driving and scaling revenue, and advancing target identification, discovery, and c
- SECSEC Form S-1 filed by Bullfrog AI Holdings Inc.S-1 - BullFrog AI Holdings, Inc. (0001829247) (Filer)
- SECSEC Form 10-Q filed by Bullfrog AI Holdings Inc.10-Q - BullFrog AI Holdings, Inc. (0001829247) (Filer)
- SECSEC Form DEFA14A filed by Bullfrog AI Holdings Inc.DEFA14A - BullFrog AI Holdings, Inc. (0001829247) (Filer)
- SECSEC Form DEF 14A filed by Bullfrog AI Holdings Inc.DEF 14A - BullFrog AI Holdings, Inc. (0001829247) (Filer)
- SECBullfrog AI Holdings Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits8-K - BullFrog AI Holdings, Inc. (0001829247) (Filer)
- PRBullFrog AI Regains Compliance with Nasdaq Shareholders' Equity RequirementGAITHERSBURG, Md., April 22, 2026 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ:BFRG, BFRGW)) ("BullFrog AI" or the "Company"), a technology company using artificial intelligence ("AI") and machine learning to turn complex biomedical data into actionable insights, today announced that it has received a written notice from The Nasdaq Stock Market LLC ("Nasdaq") stating that the Company has regained compliance with the minimum stockholders' equity requirement under Nasdaq Listing Rule 5550(b)(1) (the "Stockholders' Equity Rule"). On April 21, 2026, the Company received a letter from Nasdaq notifying the Company that it had regained compliance with the Stockholders' Equity Rule, whic
- SECBullfrog AI Holdings Inc. filed SEC Form 8-K: Shareholder Director Nominations, Financial Statements and Exhibits8-K - BullFrog AI Holdings, Inc. (0001829247) (Filer)
- PRBullFrog AI Announces Participation at AACR Annual MeetingGAITHERSBURG, Md., April 14, 2026 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ:BFRG, BFRGW)) ("BullFrog AI" or the "Company"), a technology company using artificial intelligence ("AI") and machine learning to turn complex biomedical data into actionable insights, today announced its participation as an exhibitor at the American Association for Cancer Research (AACR) Annual Meeting 2026. The AACR Annual Meeting will be held from April 17-22 at the San Diego Convention Center in San Diego, California. Companies, researchers, and other conference attendees who are interested in meeting with the BullFrog AI team should visit booth 2957 or contact Steven Seegers at steven.seegers@bul
- SECBullfrog AI Holdings Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits8-K - BullFrog AI Holdings, Inc. (0001829247) (Filer)
- PRBullFrog AI Provides Business Update: Strengthened Balance Sheet Supports Continued Execution as Company Aims to Ramp Commercial Activity with Global Pharmaceutical and Biotechnology PartnersGAITHERSBURG, Md., April 13, 2026 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ:BFRG, BFRGW)) ("BullFrog AI" or the "Company"), a technology company using artificial intelligence and machine learning to turn complex biomedical data into actionable insights, today issued the following letter to shareholders from Vin Singh, Founder and CEO: Dear Fellow Shareholders, BullFrog AI enters the second quarter of 2026 well-capitalized, at commercial stage, and in active discussions with consequential pharmaceutical and biotechnology organizations. We just closed our first agreement with a top 5 global pharmaceutical company, secured the financial runway to execute our strategy into late
- SECSEC Form 424B5 filed by Bullfrog AI Holdings Inc.424B5 - BullFrog AI Holdings, Inc. (0001829247) (Filer)
- SECBullfrog AI Holdings Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits8-K - BullFrog AI Holdings, Inc. (0001829247) (Filer)
- SECBullfrog AI Holdings Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits8-K - BullFrog AI Holdings, Inc. (0001829247) (Filer)
- PRBullFrog AI Announces Commercial Agreement with Top 5 Global Pharmaceutical Company to Identify and Prioritize Therapeutic Target in Major Depressive DisorderCommercial agreement serves as high-profile third party validation of BullFrog AI's proprietary capabilities Agreement utilizes BullFrog AI's end-to-end analytical AI platform to accelerate drug discovery and development program GAITHERSBURG, Md., March 30, 2026 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ:BFRG, BFRGW)) ("BullFrog AI" or the "Company"), a technology company using artificial intelligence ("AI") and machine learning to turn complex biomedical data into actionable insights, today announced a commercial agreement with a top 5 global pharmaceutical company in 2025 by revenue ("Customer"), to apply the Company's proprietary bfLEAP® platform to identify and prioritize
- PRBullFrog AI Unveils bfARENAS™ Scenario-based Decision EngineGAITHERSBURG, Md., March 25, 2026 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ:BFRG, BFRGW)) ("BullFrog AI" or the "Company"), a technology company using artificial intelligence ("AI") and machine learning to turn complex biomedical data into actionable insights, today unveiled bfARENAS™, a new scenario-based decision engine for pharmaceutical portfolio strategy and clinical trial design, bolstering its end-to-end AI intelligence workflow. The Company will host a webinar in partnership with Xtalks Life Sciences on bfARENAS™ on March 27, 2026 at 11 a.m. ET. Organizations across biotech, pharma, and clinical research operate in high-uncertainty environments where timelines are lon
- SECSEC Form 10-K filed by Bullfrog AI Holdings Inc.10-K - BullFrog AI Holdings, Inc. (0001829247) (Filer)
- PRBullFrog to Host Webinar on New Precision AI CapabilityGAITHERSBURG, Md., March 11, 2026 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ:BFRG, BFRGW)) ("BullFrog AI" or the "Company"), a technology company using artificial intelligence ("AI") and machine learning to turn complex biomedical data into actionable insights, will host a webinar in partnership with Xtalks Life Sciences, "Turning AI Recommendations into Clear, Defensible Decisions", about BullFrog AI's new precision AI capability on Friday, March 27, 2026 at 11 a.m. ET. The new AI capability advances the Company's end-to-end intelligence workflow by adding a strategic decision support layer on top of existing platforms bfPREP™ and bfLEAP®. Unlike traditional portfolio tools t
- SECBullfrog AI Holdings Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits8-K - BullFrog AI Holdings, Inc. (0001829247) (Filer)
- SECBullfrog AI Holdings Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits8-K - BullFrog AI Holdings, Inc. (0001829247) (Filer)
BFRG FAQ
5 questionsWhere does BFRG stock trade?
Bullfrog AI Holdings Inc. (BFRG) is listed on NASDAQ.What sector and industry is BFRG in?
Bullfrog AI Holdings Inc. operates in the Health Care sector, Biotechnology: Pharmaceutical Preparations industry.When did Bullfrog AI Holdings Inc. go public?
Bullfrog AI Holdings Inc. (BFRG) completed its IPO in 2023.What companies are similar to BFRG?
Notable peers in the same industry include LLY (Eli Lilly and Company), JNJ (Johnson & Johnson), AZN (AstraZeneca PLC), ABBV (AbbVie Inc.), MRK (Merck & Company Inc.). Compare BFRG side-by-side with any of them on Quantisnow.How can I track BFRG on Quantisnow?
Quantisnow aggregates Bullfrog AI Holdings Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow BFRG to receive live email and push alerts on every new disclosure.